VLY-686 (Tradipitant)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of GastroparesisNCT02970968Vanda PharmaceuticalsPhase 2Completed2018-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.